Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
📧 Sign up to get email alerts when something new happens for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease [Phase 3]
Phase 3 trial evaluating satralizumab for efficacy, safety, pharmacokinetics, and pharmacodynamics in MOGAD.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease [Phase 3]
This clinical trial update reports an ongoing Phase 3 study evaluating satralizumab for Myelin Oligodendrocyte Glycoprotein Antibody-Associa…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Headache Prevalence and Phenotype in Myelin Oligodendrocyte Glycoprotein Antibody -Associated Disease (MOGAD)
A clinical trial update describes headache prevalence and phenotype in patients with myelin oligodendrocyte glycoprotein antibody-associated…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD) [Phase 3]
Phase 3 clinical trial evaluating Rozanolixizumab for efficacy and safety in adults with MOG antibody-associated disease is actively not rec…
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Tongji NADs Cohort
Tongji Hospital has announced a NADs cohort trial covering multiple autoimmune neurological diseases including multiple sclerosis and relate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease [Phase 2, Phase 3]
The document reports on a phase 2/phase 3 clinical trial evaluating the safety and efficacy of tocilizumab in patients with myelin oligodend…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
This clinical trial is a multicenter retrospective observational study evaluating the clinical impact of AI-assisted MRI care in multiple sc…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
An ongoing sponsor-initiated study is evaluating metabolism, connectivity, and ultra-high-field mesoscopic imaging to uncover mechanisms of …
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis. [NA]
This clinical trial update reports on the frequency of FCGR3A gene polymorphisms in patients with Neuromyelitis Optica Spectrum Disorders, M…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]
An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD) [NA]
This clinical trial is evaluating the efficacy and safety of Calculus Bovis Sativus (CBS) for idiopathic inflammatory demyelinating diseases…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
Sun Yat-Sen Memorial Hospital is conducting a cohort study of CNS idiopathic inflammatory demyelinating diseases and is currently recruiting…
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: National, Multicentric Registry Study on Neuroimmunological Diseases in China
National multicentric registry in China studying neuroimmunological diseases is currently recruiting, covering conditions such as Multiple S…